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Abstract
Background: The burden of chronic disease and multimorbidity is rapidly increasing. Self-management support
interventions are effective in reduce cost, especially when targeted at a single disease group; however, economical
evidence of such complex interventions remains scarce. The objective of this study was to evaluate a cost-
effectiveness analysis of a tele-based health-coaching intervention among patients with type 2 diabetes (T2D),
coronary artery disease (CAD) and congestive heart failure (CHF).
Methods: A total of 1570 patients were blindly randomized to intervention (n = 970) and control (n = 470) groups. The
intervention group received monthly individual health coaching by telephone from a specially trained nurse for 12-
months in addition to routine social and healthcare. Patients in the control group received routine social and health
care. Quality of life was assessed at the beginning of the intervention and follow-up measurements were made after
12 months health coaching. The cost included all direct health-care costs supplemented with home care and nursing
home-care costs in social care. Utility was based on a Health Related Quality of Life (HRQoL) measurement (15D
instrument), and cost effectiveness was assessed using incremental cost-effectiveness ratios (ICERs).
Results: The cost-effectiveness of health coaching was highest in the T2D group (ICER €20,000 per Quality-Adjusted Life
Years [QALY]). The ICER for the CAD group was more modest (€40,278 per QALY), and in the CHF group, costs increased
with no marked effect on QoL. Probabilistic sensitivity analysis indicated that at the societal willingness to pay threshold
of €50,000 per QALY, the probability of health coaching being cost effective was 55% in the whole study group.
Conclusions: The cost effectiveness of health coaching may vary substantially across patient groups, and thus
interventions should be targeted at selected subgroups of chronically ill. Based on the results of this study, health
coaching improved the QoL of T2D and CAD patients with moderate costs. However, the results are grounded on a short
follow-up period, and more evidence is needed to evaluate the long-term outcomes of health-coaching programs.
Trial registration: NCT00552903 [Prospectively registered, registration date 1st November 2007, last updated 3rd
February 2009].
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Background
In the European Union (EU), approximately 50 million
people live with multiple chronic diseases, and this is
one of the leading causes of growing healthcare costs. It
is estimated that chronic diseases inflict 70–80% of total
healthcare costs in EU countries [1]. In Finland (pop. 5.4
million in 2011), 37.2% of the population had at least
one chronic disease or health problem in 2011 [2].
Therefore, how to manage the burden of chronic disease
is a key question for policy makers.
Self-management support interventions are widely recog-
nized as a promising approach to enhance health outcomes
and contain costs in chronic care. Previous studies suggest
that self-management interventions improve clinical out-
comes, self-efficacy, quality of life and self-management be-
haviour [3–5]. They have also been successful in reducing
hospitalization and healthcare costs, especially when the
intervention has been focused on a single disease. The most
promising results have been observed in respiratory and
cardiovascular diseases [6].
However, the economic evaluation (cost effectiveness
and cost-utility analysis) of self-management interven-
tions is still scarce, although cost-effectiveness analysis
has become a standard practice in evaluating, e.g. med-
ical treatments [7–10]. This may be due to methodo-
logical challenges; self-management interventions are
often complex interventions, and the standard experi-
mental setting, a randomized controlled trial (RCT), is
difficult to put into practice in real life [11, 12]. Further-
more, routinely collected administrative and clinical data
typically lack the important measurements needed in the
assessment of self-management interventions [13].
Health coaching is patient-oriented health promotion
and education within a coaching context that emerged
from the motivational interviewing concept [3]. The pur-
pose of health coaching, as defined by Palmer et al. [14] is
to motivate the patient to achieve a goal that enhances
quality of life and improves health. A coach’s role is to help
patients weigh options, make choices and plan and identify
challenges to help them change for the better [14].
Telephone-based health-coaching intervention was
launched in November 2007 in the Päijät-Häme area in
Finland. The number of inhabitants above the age of
65 years was increasing faster than in other parts in
Finland, and costs of delivering secondary care were
high, especially for chronic conditions, such as heart fail-
ure, coronary heart disease and diabetes. The health-
coaching call centre was established in the city of Lahti
as a public–private partnership, where the public partner
was responsible for the primary care and secondary care
in the region.
The objective of this study was to evaluate the cost ef-
fectiveness of 12 months of telephone-based health-
coaching intervention (the TERVA trial) for chronically
ill patients in Finland. This was tested using a two arm
trial with three patient groups with sub optimally con-
trolled disease: type 2 diabetes mellitus (T2D), coronary
artery disease (CAD) or congestive heart failure (CHF).
The primary outcomes of the TERVA trial, the short-
term clinical outcomes at 12 months follow-up, have
been reported earlier [15].
Methods
The total population of the area involved the health
coaching program was approximately 112 000. Patients
were recruited from electronic patient laboratory records
in secondary care according to laboratory inclusion cri-
teria (Glycated Hemoglobin (HbA1c) >7 or total choles-
terol >4,5 or low density lipoprotein (LDL) >2.3 previous
six months). In this phase we identified about 5 500 pa-
tients. After that research nurse identified those patients
who were applicable for coaching according to inclusion
and exclusion criteria from patients’ medical records,
2594 patient fulfilled inclusion criteria and were invited to
participate. The information and consent letters were sent
to the patients. 1535 identified patients, gave consent and
were randomized to either control (C) or intervention (I)
groups. At the baseline, there were no significant differ-
ences in age, sex, self- reported duration of disease and
age of diagnosed, blood pressure (systolic, diastolic), total
cholesterol, high density lipoprotein (HDL), LDL, body
mass index (BMI), waist circumference, daily smokers,
lipid lowering medication, HbA1c, oral antidiabetic drug
and insulin, oral antidiabetic drug, insulin and NYHA-
class between intervention and control groups [15].
Randomization 2:1 ratio was intentional for practical rea-
sons. Statistical power calculations were conducted to ver-
ify that the imbalance would not cause problems. The
intervention group received monthly individual health
coaching for 12 months in addition to routine social and
healthcare. Patients with multiple morbidities received
coaching for each disease according to their personal pri-
orities. Patients in the control group received routine so-
cial and health care e.g. visited diabetes nurse and doctors
in primary and secondary care. Patients with more than
one disease were allocated to following hierarchy: CHF-
CAD- T2D [15]. Of these 1535 participants, 998 patients
with complete baseline and follow-up data were included
in the cost-effectiveness analysis (83 patients in the CHF
group (I 56, C 27), 192 in the CAD group (I 124, C 68)
and 723 in the T2D group (I 505, C 218). A total of 537
patients were lost in the follow-up. The detailed recruit-
ment and randomization process has been published pre-
viously [15].
Intervention
Eight experienced certified nurses and public health
nurses were hired and trained in the motivational
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interviewing technique and coaching by telephone.
Health coaches had access and the possibility to docu-
ment patient health status into the primary and second-
ary care electronic health records (EHR), but they were
not integrated in the care teams in the primary care
centres. A more complete description of the health-
coaching intervention process can be found in [15].
The health-coaching intervention included eight key
recommendations developed by Pfizer Health Solution
(PHS) and were adjusted for the Finnish healthcare sys-
tem and Finnish evidence-based guidelines. The eight
recommendations included: 1) know how and when to
call for help, 2) learn about the condition and set goals,
3) take medicines correctly, 4) get recommended tests
and services, 5) act to keep the condition well, 6) make
lifestyle changes and reduce risk, 7) build on strengths
and overcome obstacles and 8) follow up with specialists
and appointments. Coaching was technology supported
and utilized a traffic-light system for patients’ progress
in relation to the key recommendations. Patient’s self-
management booklets supported progress towards the
key recommendations. Each disease had a separate
booklet prepared in collaboration with the Finnish Heart
Association and the Diabetes Association. The patients
in the intervention group were called approximately 10–
12 times during the intervention period.
Data
Health-related quality of life
HRQoL was measured by using 15D [16].15D is a gen-
eric, self-administered instrument for measuring HRQoL
among adults (age over 16 years) with 15 dimensions:
mobility, vision, hearing, breathing, sleeping, eating,
speech, excretion, usual activities, mental function, dis-
comfort and symptoms, depression, distress, vitality and
sexual activity. Completing the questionnaire takes 5–10
min. Each dimension has five ordinal levels, and 15D
can be used as a profile measure or a single index num-
ber on a scale of 0–1 (0 dead, 1 completely healthy).
Typically, 15D is used to measure the effectiveness of a
single intervention [16, 17] and performs well in com-
parison to SF-36 as a HRQoL-instrument [18].
The baseline HRQoL data were collected by sending
the 15D questionnaire to patients in the intervention
and control groups at the beginning of the health-
coaching intervention and follow-up measurements were
made when the coaching finished after 12 months.
Cost data
Data for the costs and use of social and healthcare ser-
vices were collected from the National registries main-
tained by the National Institute for Health and Welfare
(Dnro THL/119/5.05.00/2015). These registers included
the hospital benchmarking database the National
Discharge Registry (HILMO) and Care Registers for
Social Welfare (SosiaaliHILMO). Using a unique patient
identification code, patient cohorts were linked to the
registers, and all use of social and healthcare during 1-
year follow-up was included for each individual. Second-
ary care data included the use of hospital outpatient care
(all types of visits) and hospital admissions (diagnosis-re-
lated groups [DRGs]). Social care data included all types
of long- and short-term institutionalized care, housing
and residential services and home care services.
Hospitalizations and hospital outpatient visits due to
any cause were extracted from the Hospital Discharge
Register based on the International Classification of
Diseases 10th revision (ICD-10) codes, the Finnish ver-
sion of the Nordic Classification of Surgical Procedures
(NCSP) codes for diagnostic and treatment procedures
and the respective NordDRG patient grouping classifica-
tions. The DRG cost weights for hospitalizations and
outpatient visits were based on individual-level cost-
accounting data from several hospitals. The unit cost es-
timates for social care encounters and bed days were de-
rived from the national price list for unit costs of
healthcare services in Finland [19].
The use of primary healthcare resources was collected
directly from the patient administration system (PAS)
containing patient-level data abstracts from the elec-
tronic patient records. The PAS data included contact
types (such as a visit, phone call or electronic messa-
ging), patient’s age, the diagnosis (ICD-10) or the reason
for encounter (ICPC-2) and the employee category of
the healthcare professional in the contact. Extracting the
patient-level data from the patient administration sys-
tems (with diagnosis and activity information) made it
possible to group each individual encounter type by the
Ambulatory and Primary Care Related Patient Groups
(APR) grouper software, a grouping system equivalent to
DRGs used in hospital care [20]. The batch grouper soft-
ware assigned each individual patient encounter in one
of the 44 APR groups. After grouping, each of the 44
APR groups in the sample was assigned a cost weight in-
dicating the relative consumption of resources. Cost
weights were based on large samples of time measure-
ments in primary care contacts and procedures. All costs
were deflated using the price index for public healthcare
provided by Statistics Finland.
Statistical analysis
We report differences in the mean costs and outcomes
and the corresponding cost-effectiveness ratio (ICER).
ICER is defined by the difference in cost between the
intervention and control, divided by the difference in
their effect.
Uncertainty in the ICER estimates was accounted for
by generating bootstrap 1000 replicates of the dataset, a
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method widely used in health economic evaluations
[21, 22] to study the likelihood of effectiveness of an
intervention in relation to the costs of care induced by
the intervention [23]. Probabilistic sensitivity analysis
was completed by calculating the cost-effectiveness ac-
ceptability curve (CEAC) derived from the bootstrap
replicates. CEAC indicates the probability for cost ef-
fectiveness of the intervention at different levels of will-
ingness to pay for the additional health outcome [24].
Results
The overall incremental ICER was €48,000 per QALY.
The cost effectiveness of health coaching was highest in
the T2D group (ICER €20,000 per QALY). The ICER for
the CAD group was more modest (€40,278 per QALY),
although the improvement in QoL was greatest in this
group and also exceeded the threshold for a clinically
significant change in 15D (>0.015 [25]). In the CHF
group, the effect on QoL was slightly negative at an in-
creased cost (Table 1).th=tlb=
Figure 1 presents the bootstrapped results among the
whole study group displayed in a cost-effectiveness
plane. There was considerable uncertainty in the ICER
of the intervention.
The cost-effectiveness plane for HRQoL (15D) after
health coaching showed that the intervention was more
effective compared to care as usual but also more costly.
Of the bootstrapped ICERs, 89% fell into the northeast
quadrant, indicating increased QoL at an incremental
cost; 9% of the points fell into the southeast quadrant,
indicating increased QoL at a decreased cost. Only 2%
of the data points fell into the northwest quadrant, and
less than 1% fell into the southwest quadrant, suggesting
a very small probability for a decrease in QoL at an in-
cremental or decreased cost (Fig. 1).
Figure 2 shows the incremental CEACs for the whole
participant group and for the disease-specific subgroups.
At no willingness to pay for incremental QALY, the
probability of health-coaching cost effectiveness was less
than 10% among all participants. At a willingness to pay
€46,000 per QALY, the probability that the intervention
is cost effective was over 50%. If the decision maker
were willing to pay €50,000 per QALY, the probability of
cost-effectiveness is 55%. The CEAC for the T2D group
showed over 50% probability of cost effectiveness at a
willingness to pay €20,000 per QALY. At a willingness to
pay €50,000 per QALY, the probability that the interven-
tion is cost effective for the T2D patients was 75%.
Discussion
In this study, the cost effectiveness of 12 months
telephone-based health-coaching intervention among
three groups of chronically ill patients with unmet treat-
ment goals was evaluated. The overall ICER was €48,000
per QALY. Further probabilistic sensitivity analysis
showed a 55% probability of cost effectiveness if the de-
cision maker were willing to pay €50,000 per QALY. In-
vestments in programs for coaching patients may well
be acceptable. Further disease-specific analyses indicated
that the ICER for health coaching was lowest in the T2D
group with a moderately low cost per QALY of €20,000.
In the CAD group, the cost per QALY was higher
(€40,278), and in the CHF group the effect on QoL was
slightly negative at an increased cost.
Graves et al. [9] reported similar results ($29,375 per
QALY, approximately €21,045 per QALY) for patients
with T2D or hypertension after 1-year telephone-
delivered intervention for physical activity and diet in a
low socioeconomic area in Australia. Jacobs-van-der
Bruggen et al. [26] analysed seven lifestyle interventions
among patients with T2D and simulated the long-term
outcomes. Health improvements were achieved at rea-
sonable costs (≤ €50,000 per QALY), and average gained
health-adjusted life years were 0.01–0.14 QALY per par-
ticipant. Results in the CHF group somewhat contra-
dicted the results of previous studies [5, 6]. However, the
small number of patients (I 56, C 27) may have diluted
the evidence in this subgroup or the coaching program
did not support those people.
In this study, cost per QALY was found to be lowest
in the T2D group. An improvement in QALY (0.008)
was achieved with a small increase in the cost of care
(€160 per patient). In the CAD group, both the improve-
ments in QoL (0.018) as well as the increase in cost
(€725 per patient) were higher. Possible explanations for
the difference between these groups can be found in the
medical history and the care received by the patients
prior to the intervention. Most CAD patients were
recruited for health coaching a few months after an
acute percutaneous transluminal coronary angioplasty
Table 1 Incremental costs, quality of life and cost-effectiveness ratios in the disease subgroups and in the whole study group
Costs (€), mean (95% CI) QoL (15D), mean (95% CI) ICER (€/QALY)
Intervention Control Incremental cost Intervention Control Incremental effect
Type 2 diabetes 1948 (1673–2222) 1788 (1204–2371) 160 (−406–726) 0.008 (0.003– 0.014) 0.000 (−0.009–0.009) 0.008 (−0.002–0.018) 20 000
Coronary artery disease 2510 (1806–3214) 1785 (984–2585) 725 (−389–1839) 0.019 (0.007–0.030) 0.001 (−0.014–0.016) 0.018 (−0.001–0.037) 40 278
Congestive heart failure 4469 (1955–6983) 2214 (−105–4533) 2255 (−1669–6180) 0.013 (−0.007–0.032) 0.015 (−0.015–0.046) −0.003 (−0.037–0.032 -
All 2256 (1940–2571) 1824 (1345–2302) 432 (−135–999) 0.011 (0.006 − 0.015) 0.002 (−0.006–0.009) 0.009 (0.000–0.018) 48 000
CI confidence interval, QoL Quality of Life, ICER incremental cost-effectiveness ratio, QALY quality- adjusted life years
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operation. Motivation to lifestyle changes and self-
management are high after an acute cardiovascular at-
tack [27]. The proximity of this severe incident may have
activated the CAD patients in their self-care and health-
care service use and therefore fortified the effect of the
intervention on the QoL increased cost in this group.
Another reason for the increased cost in this group can
be attributed to the standard follow-up visits after an
acute cardiovascular attack or intervention in secondary
care. Further, in care as usual, the diabetes patients re-
ceive treatment and self-care support from specially
trained diabetes nurses, while the self-care support for
CAD patients is not arranged as systematically in the
present healthcare provision. This may explain the dif-
ference in the increased cost of care between the groups.
This study is among the few cost-effectiveness eval-
uations of health coaching for the chronically ill car-
ried out in a real-life setting and using RCT design.
Another strength of the present study was the use of
national registries and local patient administration
systems, including all social and healthcare services
and their costs in the follow-up. Many studies pub-
lished so far have relied on the self-reported use of
services.
Fig. 1 Distribution of bootstrapped incremental costs and health-related quality of life
Fig. 2 Cost-effectiveness acceptability curves for all participants and diagnosis-based subgroups
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One clear shortcoming in the study was the rather
short follow-up period. Significant health behaviour
changes take at least 6 months and may have delayed
the impact in clinical changes [28, 29]. A new, long term
follow-up study, using the cohorts in the present study
and based on National registries, has been set up to clar-
ify the effects by analysing the differences in distal end
points (such as complications in T2D and major events
in CAD) and the differences in cumulated health and so-
cial care costs.
Immediately after the TERVA trial, only the clinical re-
sults and direct cost data were available for the regional
decision makers, and the health-coaching program was
cancelled. This may be a common problem with the
evaluation of self-management and other preventive in-
terventions, which typically focus on short-term health
outcomes [30]. In this study, a closer exploration using
QALYs and subgroup analysis revealed that closing the
coaching program may have been questioned on the
basis of the cost-effectiveness analysis.
We conclude that the assessment of cost effectiveness
in preventive actions is demanding and thus requires
careful and balanced analyses to sufficiently inform the
decision makers on preferred choices.
Conclusions
Decision makers in health care are actively seeking inter-
ventions leading to better health outcomes with a lower
cost, but the evidence on cost effectiveness of self-
management interventions is still scarce. In this RCT
conducted in a real-life primary care setting, health
coaching improved the QoL of T2D and CAD patients
with moderate costs in the short-term follow-up. The re-
sults of our study suggest that health coaching should be
targeted to selected patient groups. However, the follow-
up period was probably too short to evaluate the cost-
effectiveness of health-coaching intervention and a long-
term evaluation is needed.
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